Compare KHC & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KHC | GEHC |
|---|---|---|
| Founded | 1869 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 32.1B |
| IPO Year | 2015 | 2022 |
| Metric | KHC | GEHC |
|---|---|---|
| Price | $23.04 | $73.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $24.88 | ★ $89.67 |
| AVG Volume (30 Days) | ★ 14.8M | 3.4M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | ★ 6.88% | 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | ★ $24,942,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | $0.59 | $4.50 |
| P/E Ratio | ★ N/A | $16.05 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $21.04 | $59.95 |
| 52 Week High | $30.42 | $89.77 |
| Indicator | KHC | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 52.63 | 50.45 |
| Support Level | $21.99 | $69.58 |
| Resistance Level | $24.82 | $75.33 |
| Average True Range (ATR) | 0.57 | 1.76 |
| MACD | 0.20 | 0.67 |
| Stochastic Oscillator | 79.69 | 83.13 |
In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).